Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald Trump continues to ramp up pressure on the biopharma industry.

MORRISTOWN, N.J. and CAMBRIDGE, Mass., May 14, 2025 /PRNewswire/ -- Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s last program in the process. IGM responded by laying off 80% of its staff and closing most of its lab and ...

Morristown-based Sanofi will spend $20 billion on its U.S. operations through 2030. It also has a Massachusetts presence. Sanofi has roughly 1,900 employees in Morristown at the M Station ...

Sanofi plans to boost its U.S.-based research and development and manufacturing investments to at least $20 billon over the next five years. In a May 14 press release, the French multinational ...

(Reuters) - Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining other drugmakers in expanding their U.S. presence in response ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Investing.com -- Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3. The outlook for the company has been revised from ...

We came across a bullish thesis on Sanofi (SNY) on Substack by Business Model Mastery. In this article, we will summarize the bulls’ thesis on SNY. Sanofi (SNY)’s share was trading at $51.06 ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

PARIS, May 15 (Reuters) - France's finance minister criticised on Thursday a decision by French drugmaker Sanofi (SASY.PA), opens new tab to invest at least $20 billion in the United States ...